SMITH IAN F
SEC insider (Form 3/4/5 filer). CIK 0001197032. Director at Solid Biosciences Inc. (SLDB) and 3 other issuers. 23 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in CHARLESTOWN, MA.
Companies SMITH IAN F has filed insider reports for
- Solid Biosciences Inc. (SLDB): Director
- Foghorn Therapeutics Inc. (FHTX): Director
- Odyssey Therapeutics, Inc. (ODTX): Director
- Stoke Therapeutics, Inc. (STOK): Director, Officer, Chief Executive Officer
SMITH IAN F
CIK: 0001197032
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 2, 2026SLDB
Solid Biosciences Inc.
ExerciseDirect3.4K shares- - Jul 2, 2026SLDB
Solid Biosciences Inc.
ExerciseDirect3.4K shares- - Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Options (Right to buy)
28K shares at avg. $4.08- - Jun 10, 2026SLDB
Solid Biosciences Inc.
AwardDirectDirector Stock Option (Right to Buy)
77.5K shares- - May 7, 2026ODTX
Odyssey Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
27.4K shares- - Apr 2, 2026SLDB
Solid Biosciences Inc.
ExerciseDirect3.4K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectRestricted Stock Units
129K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
193K shares- - Jan 6, 2026SLDB
Solid Biosciences Inc.
ExerciseDirect4.6K shares- - Jan 2, 2026SLDB
Solid Biosciences Inc.
AwardDirectRestricted Stock Units
13.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  SLDB Solid Biosciences Inc. | Exercise | 3,440 | - | $0 | Direct |
| Jul 2, 2026 | SLDB Solid Biosciences Inc. | Exercise | 3,440 | - | $0 | Direct |
| Jun 24, 2026 |  FHTX Foghorn Therapeutics Inc. | Award Stock Options (Right to buy) | 28,000 | $4.08 | - | Direct |
| Jun 10, 2026 | SLDB Solid Biosciences Inc. | Award Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| May 7, 2026 |  ODTX Odyssey Therapeutics, Inc. | Award Stock Option (Right to Buy) | 27,393 | - | - | Direct |
| Apr 2, 2026 | SLDB Solid Biosciences Inc. | Exercise | 3,441 | - | $0 | Direct |
| Feb 17, 2026 |  STOK Stoke Therapeutics, Inc. | Award Restricted Stock Units | 129,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 193,000 | - | - | Direct |
| Jan 6, 2026 | SLDB Solid Biosciences Inc. | Exercise | 4,573 | - | $0 | Direct |
| Jan 2, 2026 | SLDB Solid Biosciences Inc. | Award Restricted Stock Units | 13,761 | - | - | Direct |
1-10 of 23 transactions